Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manal M. Alanazi"'
Autor:
Ahmed H. Bakheit, Tanveer A. Wani, Abdulrahman A. Al-Majed, Hamad M. Alkahtani, Manal M. Alanazi, Fahad Rubayyi Alqahtani, Seema Zargar
Publikováno v:
Frontiers in Chemistry, Vol 12 (2024)
A theoretical thermodynamic study was conducted to investigate the antioxidant activity and mechanism of 1,3,4-oxadiazol-2-ylthieno[2,3-d]pyrimidin-4-amine derivatives (OTP) using a Density Functional Theory (DFT) approach. The study assessed how sol
Externí odkaz:
https://doaj.org/article/bb2e40c580bf4c75b7e0824bbdccf355
Autor:
Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Al-Mehizia, Manal M. Alanazi, Saleh Aldawas, Alaa Elwan, Hazem Elkady
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1093-1114 (2021)
Herein, a new wave of bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives have been successfully designed and synthesised. The synthesised derivatives were biologically investigated for their cytotoxic activities against HepG2 and MCF-7. Als
Externí odkaz:
https://doaj.org/article/3967d8ed03e940f084313220d5cd06f9
Autor:
Mohammed M. Alanazi, Ahmad J. Obaidullah, Nawaf A. Alsaif, Madhawi A. Alharbi, Manal M. Alanazi, Ibrahim H. Eissa, Hamad M. Alkahtani, Mohammed A. Dahab, Hazem Elkady
Publikováno v:
RSC Advances. 11:30315-30328
A new series of 3-methylquinoxaline-based derivatives having the same essential pharmacophoric features as VEGFR-2 inhibitors have been synthesized and evaluated for their antiproliferative activities against two human cancer cell lines, MCF-7 and He
Autor:
Abdulrahman A. Almehizia, Mohammed A. Dahab, Ahmad J. Obaidullah, Hazem A. Mahdy, Nawaf A. Alsaif, Hazem Elkady, Saleh Aldawas, Manal M. Alanazi, Mohammed M. Alanazi
Publikováno v:
Bioorganic Chemistry. 110:104807
New series of [1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one and [1,2,4]triazolo[4,3-a]quinoxaline derivatives have been designed, synthesized, and biologically assessed for their anti-proliferative activities against two selected tumor cell lines MCF-7